The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abnormal Liver Development and Resistance to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Toxicity in Mice Carrying a Mutation in the DNA-Binding Domain of the Aryl Hydrocarbon Receptor
Open accessAbstract
The aryl hydrocarbon receptor (AHR) is known for its role in the adaptive and toxic responses to a large number of environmental contaminants, as well as its role in hepatovascular development. The classical AHR pathway involves ligand binding, nuclear translocation, heterodimerization with the AHR nuclear translocator (ARNT), and binding of the heterodimer to dioxin response elements (DREs), thereby modulating the transcription of an array of genes. The AHR has also been implicated in signaling events independent of nuclear localization and DNA binding, and it has been suggested that such pathways may play important roles in the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Here, we report the generation of a mouse model that expresses an AHR protein capable of ligand binding, interactions with chaperone proteins, functional heterodimerization with ARNT, and nuclear translocation, but is unable to bind DREs. Using this model, we provide evidence that DNA binding is required AHR-mediated liver development, as Ahr(dbd/dbd) mice exhibit a patent ductus venosus, similar to what is seen in Ahr(-/-) mice. Furthermore, Ahr(dbd/dbd) mice are resistant to TCDD-induced toxicity for all endpoints tested. These data suggest that DNA binding is necessary for AHR-mediated developmental and toxic signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Examination of the Ahrdbd construct in vitro revealed that after ligand binding, it retained the ability to translocate to the nucleus and dimerize with ARNT (Bunger et al., 2008).”
From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Bunger et al., 2008
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While extensive studies to explain how the presence of the NeoPGK cassette leads to hypomorphism are lacking, preliminary evidence from multiple alleles in our own laboratory suggest that the presence of the NeoPGK transgene reduces RNA expression from multiple loci, independent of direction or position (Bunger et al., 2008; Bunger et al., 2003; Lin et al., 2008; Walisser, Bunger, Glover, & Brad”
From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Bunger et al., 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Interestingly, this mutation had an unexpected influence on the neighboring NLS and the construct became constitutively nuclear.”
From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Bunger et al., 2008
The cited source says what the claim attributes to it.
In the citing paper
“Yet, in two-hybrid assays, it was shown to maintain its ligand responsiveness and its capacity to dimerize with ARNT (Bunger et al., 2008).”
From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Bunger et al., 2008
The cited source says what the claim attributes to it.
In the citing paper
“In keeping with its predicted activity, the Ahrdbd mutant could not activate Cyp1 gene expression or interact with AHREs.”
From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Bunger et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poland, A., & Knutson, J. C. (1982) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.22.040182.002505 · Cited by 2,515
The Aryl Hydrocarbon Receptor Complex
Hankinson, O. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.001515 · Cited by 1,649 · cited 3×
“Upon binding agonists such as TCDD, the AHR translocates from the cytoplasm to the nucleus, where it dimerizes with another bHLH-PAS protein known as the AHR nuclear translocator (ARNT) (Hankinson, 1995).”
BackgroundNeonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., & Mulligan, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90011-m · Cited by 1,281
Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C., & Bradfield, C. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6731 · Cited by 902
Self-citationFernández‐Salguero, P. M., Hilbert, D. M., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0210 · Cited by 835
Gradin, K., McGuire, J., Wenger, R. H., Kvietikova, I., Whitelaw, M. L., Toftgård, R., Tora, L., Gassmann, M., & Poellinger, L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5221 · Cited by 470
Carver, L. A., & Bradfield, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11452 · Cited by 428
Self-citationAh Receptor and NF-κB Interactions, a Potential Mechanism for Dioxin Toxicity
Tian, Y., Ke, S., Denison, M. S., Rabson, A. B., & Gallo, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.510 · Cited by 406
Lahvis, G. P., Lindell, S. L., Thomas, R. S., McCuskey, R. S., Murphy, C., Glover, E., Bentz, M., Southard, J., & Bradfield, C. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190256997 · Cited by 377
Self-citationThe aryl hydrocarbon receptor: studies using the AHR-null mice.
Gonzalez, F. J., & Fernández‐Salguero, P. M. (1998) · PubMed · Cited by 375
Cited by
Sorted by citations
The aryl hydrocarbon receptor: multitasking in the immune system
Stockinger, B., Meglio, P. D., Gialitakis, M., & Duarte, J. H. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120245 · Cited by 909
Denison, M. S., Soshilov, A. A., He, G., DeGroot, D. E., & Zhao, B. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr218 · Cited by 748
DiNatale, B. C., Murray, I. A., Schroeder, J. C., Flaveny, C. A., Lahoti, T. S., Laurenzana, E. M., Omiecinski, C. J., & Perdew, G. H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq024 · Cited by 651
The aryl hydrocarbon receptor: a perspective on potential roles in the immune system
Stevens, E. A., Mezrich, J. D., & Bradfield, C. A. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03054.x · Cited by 425
Self-citationOmiecinski, C. J., Heuvel, J. P. V., Perdew, G. H., & Peters, J. M. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq338 · Cited by 385
Mammalian Per-Arnt-Sim Proteins in Environmental Adaptation
McIntosh, B. E., Hogenesch, J. B., & Bradfield, C. A. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135922 · Cited by 352
Self-citation(CONTAM), E. P. O. C. I. T. F. C., Knutsen, H. K., Alexander, J., Barregård, L., Bignami, M., Brüschweiler, B. J., Ceccatelli, S., Cottrill, B., Dinovi, M., Edler, L., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5333 · Cited by 378
Marshall, N. B., & Kerkvliet, N. I. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05125.x · Cited by 202
A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-κB family
Vogel, C. F. A., & Matsumura, F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.036 · Cited by 202
AHR-mediated immunomodulation: The role of altered gene transcription
Kerkvliet, N. I. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.021 · Cited by 181
Whitehead, A., Clark, B. W., Reid, N. M., Hahn, M. E., & Nacci, D. E. (2017) · Evolutionary Applications · doi:10.1111/eva.12470 · Cited by 168
Antioxidant Functions of the Aryl Hydrocarbon Receptor
Dietrich, C. (2016) · Stem Cells International · doi:10.1155/2016/7943495 · Cited by 148
Nacci, D. E., Champlin, D. M., & Jayaraman, S. (2010) · Estuaries and Coasts · doi:10.1007/s12237-009-9257-6 · Cited by 141
Whitehead, A., Triant, D. A., Champlin, D. M., & Nacci, D. E. (2010) · Molecular Ecology · doi:10.1111/j.1365-294x.2010.04829.x · Cited by 140
Barhoover, M. A., Hall, J. M., Greenlee, W. F., & Thomas, R. S. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.059675 · Cited by 144
Common mechanism underlies repeated evolution of extreme pollution tolerance
Whitehead, A., Pilcher, W., Champlin, D. M., & Nacci, D. E. (2011) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2011.0847 · Cited by 135
Diversity as opportunity: Insights from 600 million years of AHR evolution
Hahn, M. E., Karchner, S. I., & Merson, R. R. (2017) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.02.003 · Cited by 134
Latchney, S. E., Hein, A. M., O’Banion, M. K., DiCicco-Bloom, E. M., & Opanashuk, L. A. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12130 · Cited by 139
Soshilov, A. A., & Denison, M. S. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01183-13 · Cited by 128
DiNatale, B. C., Schroeder, J. C., Francey, L. J., Kusnadi, A. R., & Perdew, G. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118570 · Cited by 117
Dioxins, the aryl hydrocarbon receptor and the central regulation of energy balance
Lindén, J., Lensu, S., Tuomisto, J., & Pohjanvirta, R. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.07.002 · Cited by 108
O’Donnell, E. F., Koch, D. C., Bisson, W. H., Jang, H. S., & Kolluri, S. K. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.549 · Cited by 105
Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease
Ravid, J. D., Kamel, M. H., & Chitalia, V. C. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00408-4 · Cited by 102
Johnson, B. P., Walisser, J. A., Liu, Y., Shen, A. L., McDearmon, E. L., Moran, S. M., McIntosh, B. E., Vollrath, A. L., Schook, A. C., Takahashi, J. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421708111 · Cited by 103
Self-citationNukaya, M., Moran, S., & Bradfield, C. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809613106 · Cited by 91
Self-citationHarrill, J. A., Hukkanen, R. R., Lawson, M., Martin, G., Gilger, B., Soldatow, V., LeCluyse, E. L., Budinsky, R. A., Rowlands, J. C., & Thomas, R. S. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.06.024 · Cited by 83
Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
Bohár, Z., Toldi, J., Fülöp, F., & Vécsei, L. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16059772 · Cited by 89
Budinsky, R. A., Schrenk, D., Simon, T. W., van den Berg, M., Reichard, J. F., Silkworth, J. B., Aylward, L. L., Brix, A., Gasiewicz, T. A., Kaminski, N. E., et al. (2013) · Critical Reviews in Toxicology · doi:10.3109/10408444.2013.835787 · Cited by 87
Murray, I. A., Gowda, K., DiNatale, B. C., Flaveny, C. A., Chiaro, C. R., Lin, J.-M., Sharma, A. K., Amin, S., & Perdew, G. H. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100045h · Cited by 84
The Aryl Hydrocarbon Receptor and the Maintenance of Lung Health
Guerrina, N., Traboulsi, H., Eidelman, D. H., & Baglole, C. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123882 · Cited by 80
Black, M. B., Budinsky, R. A., Dombkowski, A. A., Cukovic, D., LeCluyse, E. L., Ferguson, S., Thomas, R. S., & Rowlands, J. C. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs069 · Cited by 72
Aryl Hydrocarbon Receptor: A New Player of Pathogenesis and Therapy in Cardiovascular Diseases
Tao, Y., Wang, J., Zhu, K., Tang, Y., Huang, S., Shui, X., Ding, Y., Chen, C., & Lei, W. (2018) · BioMed Research International · doi:10.1155/2018/6058784 · Cited by 76
Jin, G., Moore, A. J., Head, J. L., Neumiller, J. J., & Lawrence, B. P. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq153 · Cited by 69
Consequences of AhR Activation in Steady-State Dendritic Cells
Simones, T., & Shepherd, D. M. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq354 · Cited by 73
Receptor- and Reactive Intermediate-Mediated Mechanisms of Teratogenesis
Wells, P. G., Lee, C. J. J., McCallum, G. P., Perstin, J., & Harper, P. A. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_6 · Cited by 69
Structural basis for the ligand-dependent activation of heterodimeric AHR-ARNT complex
Diao, X., Shang, Q., Guo, M., Huang, Y., Zhang, M., Chen, X., Liang, Y., Sun, X., Zhou, F., Zhuang, J., et al. (2025) · Nature communications · doi:10.1038/s41467-025-56574-7 · Cited by 72
“Upon ligand binding to its PAS-B domain, the AHR in the cytosolic complex undergoes conformationalchanges,likely exposing the nuclear localization signal (NLS) near its bHLH domain to facilitate nuclear translocation 24,25 .”
Furness, S. G. B., & Whelan, F. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.09.004 · Cited by 63
Relevance of the Aryl Hydrocarbon Receptor (AhR) for Clinical Toxicology
Bradshaw, T. D., & Bell, D. R. (2009) · Clinical Toxicology · doi:10.1080/15563650903140423 · Cited by 62
The role of endogenous aryl hydrocarbon receptor signaling in cardiovascular physiology
Zhang, N. (2011) · Journal of Cardiovascular Disease Research · doi:10.4103/0975-3583.83033 · Cited by 62
Molecular targets that link dioxin exposure to toxicity phenotypes
Yoshioka, W., Peterson, R. E., & Tohyama, C. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.12.005 · Cited by 61
Tappenden, D. M., Lynn, S. G., Crawford, R. B., Lee, K., Vengellur, A., Kaminski, N. E., Thomas, R. S., & LaPres, J. J. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.05.004 · Cited by 60
Wheeler, J. L. H., Martin, K. C., & Lawrence, B. P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201341 · Cited by 61
Casado, F. L., Singh, K. P., & Gasiewicz, T. A. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.01.005 · Cited by 59
Homeostatic control of xeno- and endobiotics in the drug-metabolizing enzyme system
Bock, K. W. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.04.009 · Cited by 55
Jenny, M. J., Karchner, S. I., Franks, D. G., Woodin, B. R., Stegeman, J. J., & Hahn, M. E. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp116 · Cited by 54
Lee, J., Prokopec, S. D., Watson, J. D., Sun, R., Pohjanvirta, R., & Boutros, P. C. (2015) · BMC Genomics · doi:10.1186/s12864-015-1840-6 · Cited by 53
Moffat, I. D., Boutros, P. C., Chen, H., Okey, A. B., & Pohjanvirta, R. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-263 · Cited by 52
Cardiac Myocyte-Specific AHR Activation Phenocopies TCDD-Induced Toxicity in Zebrafish
Lanham, K. A., Plavicki, J. S., Peterson, R. E., & Heideman, W. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu111 · Cited by 51
Bock, K. W. (2013) · Biological Chemistry · doi:10.1515/hsz-2012-0340 · Cited by 45
Hecht, E., Zago, M., Sarill, M., de Souza, A. R., Gomez, A. V., Matthews, J. B., Hamid, Q. A., Eidelman, D. H., & Baglole, C. J. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.08.023 · Cited by 45
Boutros, P. C., Yao, C. Q., Watson, J. D., Wu, A. H., Moffat, I. D., Prokopec, S. D., Smith, A. B., Okey, A. B., & Pohjanvirta, R. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.12.010 · Cited by 44
Sarill, M., Zago, M., Sheridan, J. A., Nair, P. K., Matthews, J. B., Gomez, A. V., Roussel, L., Rousseau, S., Hamid, Q. A., Eidelman, D. H., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.007 · Cited by 42
AhR-mediated gene expression in the developing mouse telencephalon
Gohlke, J. M., Stockton, P. S., Sieber, S. O., Foley, J. F., & Portier, C. J. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.05.067 · Cited by 44
Jin, G., Winans, B., Martin, K. C., & Lawrence, B. P. (2014) · European Journal of Immunology · doi:10.1002/eji.201343980 · Cited by 41
Angrish, M. M., Jones, A. D., Harkema, J. R., & Zacharewski, T. R. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr226 · Cited by 40
TCDD dysregulation of 13 AHR-target genes in rat liver
Watson, J. D., Prokopec, S. D., Smith, A. B., Okey, A. B., Pohjanvirta, R., & Boutros, P. C. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.12.004 · Cited by 38
Zago, M., Sheridan, J. A., Nair, P. K., de Souza, A. R., Gallouzi, I., Rousseau, S., Marco, S. D., Hamid, Q. A., Eidelman, D. H., & Baglole, C. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074953 · Cited by 38
Bui, P. H., Solaimani, P., Wu, X., & Hankinson, O. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.12.009 · Cited by 37
Souder, J. P., & Gorelick, D. A. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz075 · Cited by 38
Nukaya, M., Walisser, J. A., Moran, S. M., Kennedy, G. D., & Bradfield, C. A. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq305 · Cited by 38
Self-citationFaber, S. C., Soshilov, A. A., Giani Tagliabue, S., Bonati, L., & Denison, M. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092692 · Cited by 36
Soshilov, A. A., Motta, S., Bonati, L., & Denison, M. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072474 · Cited by 36
Lahoti, T. S., Boyer, J. A., Kusnadi, A. R., Muku, G. E., Murray, I. A., & Perdew, G. H. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv178 · Cited by 36
Microbiota Metabolism Promotes Synthesis of the Human Ah Receptor Agonist 2,8-Dihydroxyquinoline
Hubbard, T. D., Liu, Q., Murray, I. A., Dong, F., Miller, C. A., Smith, P. B. W., Gowda, K., Lin, J.-M., Amin, S., Patterson, A. D., et al. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00946 · Cited by 35
AHR toxicity and signaling: Role of TIPARP and ADP-ribosylation
Matthews, J. B. (2017) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.01.013 · Cited by 32
Nault, R., Karmaus, A. L., Dere, E., & Zacharewski, T. R. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.08.013 · Cited by 32
Nukaya, M., & Bradfield, C. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.026 · Cited by 31
Self-citationNault, R., Fader, K. A., Harkema, J. R., & Zacharewski, T. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184842 · Cited by 31
Ahmed, S., Wang, A., Celius, T., & Matthews, J. B. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft274 · Cited by 29
Yao, C. Q., Prokopec, S. D., Watson, J. D., Pang, R., P’ng, C., Chong, L. C., Harding, N. J., Pohjanvirta, R., Okey, A. B., & Boutros, P. C. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.02.001 · Cited by 28
Lo, R., Celius, T., Karmaus, A. L., Dere, E., MacPherson, L., Harper, P. A., Zacharewski, T. R., & Matthews, J. B. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.08.016 · Cited by 28
Franchini, A. M., Myers, J. R., Jin, G.-B., Shepherd, D. M., & Lawrence, B. P. (2019) · ImmunoHorizons · doi:10.4049/immunohorizons.1900004 · Cited by 23
Corrada, D., Denison, M. S., & Bonati, L. (2017) · Molecular BioSystems · doi:10.1039/c7mb00005g · Cited by 24
Houser, C. L., & Lawrence, B. P. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100936 · Cited by 24
The aryl hydrocarbon receptor as a model PAS sensor
Vazquez-Rivera, E., Rojas, B. L., Parrott, J. C., Shen, A. L., Xing, Y., Carney, P. R., & Bradfield, C. A. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.11.017 · Cited by 22
Self-citationShivanna, B., Maity, S., Zhang, S., Patel, A., Jiang, W., Wang, L., Welty, S. E., Belmont, J. W., Coarfa, C., & Moorthy, B. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw071 · Cited by 21
The aryl hydrocarbon receptor reduces LC3II expression and controls endoplasmic reticulum stress
Guerrina, N., Aloufi, N., Shi, F., Prasade, K., Mehrotra, C., Traboulsi, H., Matthews, J. B., Eidelman, D. H., Hamid, Q. A., & Baglole, C. J. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00122.2020 · Cited by 21
de Souza, A. R., Traboulsi, H., Wang, X., Fritz, J. H., Eidelman, D. H., & Baglole, C. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.630427 · Cited by 21
Lew, B. J., Manickam, R., & Lawrence, B. P. (2011) · Biology of Reproduction · doi:10.1095/biolreprod.110.087544 · Cited by 22
Aryl Hydrocarbon Receptor in Health and Disease
Li, H., Fan, Y., Liu, J., Dong, S., Wen, B., Zhang, Y., Wang, X., Duan, X., Hu, Y., Yan, Z., et al. (2025) · MedComm · doi:10.1002/mco2.70426 · Cited by 22
Esteban, J., Sánchez-Pérez, I., Hamscher, G., Miettinen, H. M., Korkalainen, M., Viluksela, M., Pohjanvirta, R., & Håkansson, H. (2021) · Reproductive Toxicology · doi:10.1016/j.reprotox.2021.02.004 · Cited by 20
Role of the AHR and its Structure in TCDD Toxicity
Pohjanvirta, R., Korkalainen, M., Moffat, I. D., Boutros, P. C., & Okey, A. B. (2011) · Wiley eBooks · doi:10.1002/9781118140574.ch12 · Cited by 20
Muku, G. E., Blazanin, N., Dong, F., Smith, P. B. W., Thiboutot, D. M., Gowda, K., Amin, S., Murray, I. A., & Perdew, G. H. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz140 · Cited by 19
Compendium of TCDD-mediated transcriptomic response datasets in mammalian model systems
Prokopec, S. D., Houlahan, K. E., Sun, R., Watson, J. D., Yao, C. Q., Lee, J., P’ng, C., Pang, R., Wu, A. H., Chong, L. C., et al. (2017) · BMC Genomics · doi:10.1186/s12864-016-3446-z · Cited by 19
Josyula, N. S., Andersen, M. E., Kaminski, N. E., Dere, E., Zacharewski, T. R., & Bhattacharya, S. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02620-5 · Cited by 18
Tappenden, D. M., Hwang, H. J., Yang, L., Thomas, R. S., & LaPres, J. J. (2013) · Journal of Toxicology · doi:10.1155/2013/279829 · Cited by 18
Rodent Genetic Models of Ah Receptor Signaling
Wilson, R. H., & Bradfield, C. A. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1955916 · Cited by 16
“Examination of the Ahrdbd construct in vitro revealed that after ligand binding, it retained the ability to translocate to the nucleus and dimerize with ARNT (Bunger et al. 2008).”
BackgroundMethodInfluentialSelf-citationEffect of TCDD on the fate of epithelial cells isolated from human fetal palatal shelves (hFPECs)
Gao, Z., Bu, Y., Zhang, G., Liu, X., Wang, X., Ding, S., Wang, E., Shi, R., Li, Q., Fu, J., et al. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.06.016 · Cited by 16
Muku, G. E., Lahoti, T. S., Murray, I. A., Podolsky, M. A., Smith, K. J., Hubbard, T. D., Kuzu, G., Gowda, K., Amin, S., & Perdew, G. H. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.92 · Cited by 16
Generation of an Allelic Series at the Ahr Locus Using an Edited Recombinant Approach
Wilson, R. H., Carney, P. R., Glover, E., Parrott, J. C., Rojas, B. L., Moran, S. M., Yee, J. S., Nukaya, M., Goetz, N. A., Rubinstein, C. D., et al. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab005 · Cited by 15
Self-citationAh Receptor Binding to its Cognate Response Element is Required for Dioxin-Mediated Toxicity
Perdew, G. H. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn220 · Cited by 15
Riddick, D. S. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.001009 · Cited by 15
Oka, K., Kohno, S., Ohta, Y., Guillette, L. J., Iguchi, T., & Katsu, Y. (2016) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2016.05.002 · Cited by 14
History of Research on the AHR
Gasiewicz, T. A., & Henry, E. C. (2011) · Wiley eBooks · doi:10.1002/9781118140574.ch1 · Cited by 14
The Ahr2-Dependent wfikkn1 Gene Influences Zebrafish Transcriptome, Proteome, and Behavior
Shankar, P., Garcia, G. R., Du, J. K. L., Sullivan, C. M., Dunham, C. L., Goodale, B. C., Waters, K. M., Stanisheuski, S., Maier, C. S., Thunga, P., et al. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac037 · Cited by 13
Sulentic, C. E. W., Kaplan, B. L. F., & Lawrence, B. P. (2025) · Annual Review of Immunology · doi:10.1146/annurev-immunol-083122-040107 · Cited by 15
The Aryl Hydrocarbon Receptor Regulates Mouse Fshr Promoter Activity Through an E-Box Binding Site1
Teino, I., Kuuse, S., Ingerpuu, S., Maimets, T., & Tiido, T. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.111.095596 · Cited by 5
Alluli, A., James, W. R.-S., Eidelman, D. H., & Baglole, C. J. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115745 · Cited by 11
Cross-species transcriptomic analysis elucidates constitutive aryl hydrocarbon receptor activity
Sun, R., Chong, L. C., Simmons, T. T., Houlahan, K. E., Prokopec, S. D., Watson, J. D., Moffat, I. D., Lensu, S., Lindén, J., P’ng, C., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-1053 · Cited by 9
The Aryl-hydrocarbon Receptor (AhR) as a Therapeutic Target in Human Breast Cancer
Hall, J. M. (2013) · Journal of Steroids & Hormonal Science · doi:10.4172/2157-7536.1000140 · Cited by 10
Metadata
- Authors
- Bunger, M. K., Glover, E., Moran, S. M., Walisser, J. A., Lahvis, G. P., Hsu, E. L., & Bradfield, C. A.
- Affiliations
- University of Wisconsin–Madison (US)
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-07-27
- Volume
- 106
- Issue
- 1
- Pages
- 83-92
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- PMC
- PMC2563146
- OpenAlex
- W2148529156
- Cited by
- 139
- References
- 40
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 1 · 2023: 5 · 2022: 4 · 2021: 9 · 2020: 3 · 2019: 7 · 2018: 4 · 2017: 9 · 2016: 6 · 2015: 4 · 2014: 12 · 2013: 12 · 2012: 7
- FWCI
- 11.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Toxicological Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA014520)
- National Cancer Institute (T32CA009135, P01CA022484, P30CA014520)
- National Institute of Environmental Health Sciences (R01ES013566, F32ES005877, R01-ES-013566-01)
- Topics
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- aryl hydrocarbon receptor, 2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD toxicity, liver development, patent ductus venosus, dioxin response element, mouse model
- MeSH terms
- Polychlorinated Dibenzodioxins, Animals, Carcinogens, Environmental, Carrier Proteins, Cleft Palate, DNA, Fetal Proteins, Hydronephrosis, Liver, Male, Mice, Mutant Strains, Microtubule-Associated Proteins, Portal Vein, Thymus Gland, Transfection, Signal Transduction, 3T3 Cells, Receptors, Aryl Hydrocarbon, Gene Expression Regulation, Developmental, Cytochrome P-450 CYP1A1, Response Elements, Mice, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review